🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find the highest safe dose of Iodine-131 To...
Status
Completed
Location
Johns Hopkins Medical Institutions
Start Date
2007-06
Trial ID
NCT00484874
Treatments Being Tested
The purpose of the study is to assess the response rate of patients with re...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2007-01
Trial ID
NCT00490490
Treatments Being Tested
This is a multi-center, randomized, study to compare Iodine I 131 Tositumom...
Status
Withdrawn
Location
GSK Clinical Trials Call Center
Start Date
2005-09
Trial ID
NCT00319332
Treatments Being Tested
This study is for patients with newly diagnosed or relapsed multiple myelom...
Status
Completed
Location
University of Michigan
Start Date
2005-08
Trial ID
NCT00135200
Treatments Being Tested
This phase II trial studies how well tositumomab and iodine I 131 tositumom...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2007-02
Trial ID
NCT00476047
Treatments Being Tested
This is a single arm, multi-center, expanded access study of Iodine I 131 T...
Status
Completed
Location
Multiple Locations
Start Date
1998-09
Trial ID
NCT00268203
Treatments Being Tested
Comparison of rituximab versus Iodine I 131 Tositumomab Therapeutic Regimen...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-10
Trial ID
NCT00268983
Treatments Being Tested
Patients with a type of non-Hodgkin lymphoma, called follicular lymphoma an...
Status
Terminated
Location
University of Michigan
Start Date
2011-07
Trial ID
NCT01389076
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1999-05
Trial ID
NCT00003784
Mantle cell lymphoma (MCL) is a rare and aggressive type of lymphoma, with ...
Status
Completed
Location
Memorial Sloan Kettering at Basking Ridge
Start Date
2011-11-29
Trial ID
NCT01484093
Treatments Being Tested